
VIVO EPS Estimates
Meridian Bioscience, Inc.
$1.64
-$0.03(-1.80%)
22
Overall
--
Value
10
Tech
34
Quality
Market Cap
$51.31M
Volume
414.45K
52W Range
$1.20 - $6.86
Target Price
$10.00
VIVO EPS estimates: the consensus estimate for Meridian Bioscience, Inc.'s current fiscal year is -$0.70 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
VIVO EPS Estimates
- EPS estimate, current year
- $-0.70
- EPS estimate, next year
- $-0.62
- EPS growth, 3-year
- +35.98%
| Fiscal year | EPS |
|---|---|
| 2026 | $-2.59 |
| 2025 | $-2.60 |
| 2024 | $-15.17 |
| 2023 | $-9.87 |
| 2022 | $-1.04 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | VIVO | $1.64 | -1.8% | 414.45K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Meridian Bioscience, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW